Next Article in Journal
Caecal Carcinoma: A Review of 3 Cases in a Private Hospital in Lagos
Previous Article in Journal
Survival Post Surgery for Malignant Pericardial Effusion
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Clinics and Practice
Volume 1
Issue 2
10.4081/cp.2011.e39
clinpract-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Clinics and Practice is published by MDPI from Volume 11 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Intracameral Bevacizumab Administered for Non-Small Cell Lung Cancer Metastasis to Iris

by
Jonathan C. Schell
1,
Steven B. Koenig
1,
Kenneth Bastin
2 and
William J. Wirostko
1,*
1
The Eye Institute, Department of Ophthalmology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
2
Radiation Oncology Associates Ltd., St Luke’s Medical Center, Milwaukee, Wisconsin, USA
*
Author to whom correspondence should be addressed.
Clin. Pract. 2011, 1(2), e39; https://doi.org/10.4081/cp.2011.e39
Submission received: 21 April 2011 / Revised: 21 April 2011 / Accepted: 11 May 2011 / Published: 30 May 2011

Abstract

Ocular iris metastasis from lung cancer is uncommon. We report a patient with metastatic non-small cell lung cancer who was found to have a metastatic lesion to the iris. Local therapy for pain control and vision loss was administered with intracameral bevacizumab. Complete resolution of pain, improvement in vision, and near complete resolution of iris tumor were seen within two months. No ocular toxicity to anterior segment structures was detectable on corneal pachymetry and corneal specular microscopy. This is the first case report demonstrating safety and efficacy of intracameral bevacizumab for iris metastasis from non-small cell lung cancer.
Keywords: bevacizumab; non-small cell lung cancer; iris metastasis bevacizumab; non-small cell lung cancer; iris metastasis

Share and Cite

MDPI and ACS Style

Schell, J.C.; Koenig, S.B.; Bastin, K.; Wirostko, W.J. Intracameral Bevacizumab Administered for Non-Small Cell Lung Cancer Metastasis to Iris. Clin. Pract. 2011, 1, e39. https://doi.org/10.4081/cp.2011.e39

AMA Style

Schell JC, Koenig SB, Bastin K, Wirostko WJ. Intracameral Bevacizumab Administered for Non-Small Cell Lung Cancer Metastasis to Iris. Clinics and Practice. 2011; 1(2):e39. https://doi.org/10.4081/cp.2011.e39

Chicago/Turabian Style

Schell, Jonathan C., Steven B. Koenig, Kenneth Bastin, and William J. Wirostko. 2011. "Intracameral Bevacizumab Administered for Non-Small Cell Lung Cancer Metastasis to Iris" Clinics and Practice 1, no. 2: e39. https://doi.org/10.4081/cp.2011.e39

APA Style

Schell, J. C., Koenig, S. B., Bastin, K., & Wirostko, W. J. (2011). Intracameral Bevacizumab Administered for Non-Small Cell Lung Cancer Metastasis to Iris. Clinics and Practice, 1(2), e39. https://doi.org/10.4081/cp.2011.e39

Article Metrics

Back to TopTop